Syndax Pharmaceuticals, Inc.

SNDX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$154,083$295,394$74,356$221,965
Short-Term Investments$428,830$282,189$410,041$224,865
Receivables$13,871$1,227$4,057$429
Inventory$366$0$0$0
Other Curr. Assets$5,907$2,066$1,332$1,137
Total Curr. Assets$603,057$580,876$489,786$448,396
Property Plant & Equip (Net)$2,022$1,495$1,059$1,261
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$119,520$29,829$5,469$0
Tax Assets$0$0$0$0
Other NC Assets$217$680$922$0
Total NC Assets$121,759$32,004$7,450$1,261
Other Assets$0$0$0$0
Total Assets$724,816$612,880$497,236$449,657
Liabilities
Payables$11,626$9,961$4,350$5,669
Short-Term Debt$12,596$1,047$439$362
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$79,327$47,088$24,276$14,652
Total Curr. Liab.$103,549$58,096$29,065$20,683
LT Debt$333,143$588$722$20,606
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$333,143$588$722$20,606
Other Liabilities$0$0$0$0
Cap. Leases$2,058$1,635$1,161$1,073
Total Liabilities$436,692$58,684$29,787$41,289
Equity
Pref Stock$0$0$0$0
Common Stock$9$8$7$6
Retained Earnings-$1,221,158-$902,400-$693,040-$543,702
AOCI$163$218-$806$45
Other Equity$1,509,110$1,456,370$1,161,288$952,019
Total Equity$288,124$554,196$467,449$408,368
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$724,816$612,880$497,236$449,657
Net Debt$191,656-$293,759-$73,195-$200,997
Syndax Pharmaceuticals, Inc. (SNDX) Financial Statements & Key Stats | AlphaPilot